Challenges of an Open Access Screening Platform in Academia

Posted by

SELECTBIO

Edgar Specker, Head, Leibniz Institute of Molecular Pharmacology

Abstract
The lecture will describe the common workflow at the Screening Unit and the integration of the compound management system at our platform. It will give insights which show differences between an academic platform and an industrial set up exist. Additionally, our approach to collect compounds from academia will be discussed.